Evaluation of Patient’s Knowledge of Atorvastatin Information in Patient Information Leaflets: A Pre-Post Intervention Study in Thailand

References

• Nair K, Dolovich L, Cassels A, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104–110.
   PubMed Web of Science ®Google Scholar
• Tarn DM, Wenger A, Good JS, Hoffing M, Scherger JE, Wenger NS. Do physicians communicate the adverse effects of medications that older patients want to hear? Drugs Ther Perspect. 2015;31(2):68–76. doi:10.1007/s40267-014-0176-7
   PubMedGoogle Scholar
• Fosnocht D, Taylor JR, Caravati EM. Emergency department patient knowledge concerning Acetaminophen (paracetamol) in over-the-counter and prescription analgesics. Emerg Med J. 2008;25(4):213–216. doi:10.1136/emj.2007.053850
   Web of Science ®Google Scholar
• Cullen G, Kelly E, Murray FE. Patients’ knowledge of adverse reactions to current medications. Br J Clin Pharmacol. 2006;62(2):232–236. doi:10.1111/j.1365-2125.2006.02642.x
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Gürel S, Özdemir O. Turkish patients with osteoarthritis: their awareness of the side effects of NSAIDs. Turkish J Gastroenterol. 2005;16(2):89–92.
   Google Scholar
• Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. Expert Opin Drug Saf. 2016;15(4):417–426. doi:10.1517/14740338.2016.1139571
   PubMed Web of Science ®Google Scholar
• Kandula NR, Malli T, Zei CP, Larsen E, Baker DW. Literacy and retention of information after a multimedia diabetes education program and teach-back. J Health Commun. 2011;16:89–102. doi:10.1080/10810730.2011.604382
   PubMed Web of Science ®Google Scholar
• Alnouri F, Wood D, Kotseva K, Ibrahim MEA. Which statin worked best to achieve lipid level targets in a European registry? A post-hoc analysis of the EUROASPIRE III for coronary heart disease patients. J Saudi Heart Assoc. 2014;26:183–191. doi:10.1016/j.jsha.2014.04.005
   PubMedGoogle Scholar
• Liu Y, Cheng Z, Ding L, et al. Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin. Int J Clin Pharmacol Ther. 2010;48(12):798–802. doi:10.5414/cpp48798
   Web of Science ®Google Scholar
• Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532–2561. doi:10.1016/S0140-6736(16)31357-5
   PubMed Web of Science ®Google Scholar
• Jones PH, McKenney JM, Karalis DG, Downey J. Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia. Am Heart J. 2005;149(1):e1. doi:10.1016/j.ahj.2004.07.025
   Web of Science ®Google Scholar
• Bin Abdulhak AA, Vaughan-Sarrzin M, Kaboli P, et al. Temporal trends of high-intensity statin therapy among veterans treated with percutaneous coronary intervention. J Am Heart Assoc. 2018;7(5):e007370. doi:10.1161/JAHA.117.007370
   Web of Science ®Google Scholar
• Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–1421. doi:10.1345/aph.1P150
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421. doi:10.1161/circ.106.25.3143
   PubMed Web of Science ®Google Scholar
• Travis Gossey J, Whitney SN, Crouch MA, Jibaja-Weiss ML, Zhang H, Volk RJ. Promoting knowledge of statins in patients with low health literacy using an audio booklet. Patient Prefer Adherence. 2011;5:397–403. doi:10.2147/PPA.S19995
   Web of Science ®Google Scholar
• Koo MM, Krass I, Aslani P, Guzmàn WM, Le Duff M. Factors influencing consumer use of written drug information. Ann Pharmacother. 2003;37(2):259–267. doi:10.1177/106002800303700218
   PubMed Web of Science ®Google Scholar
• Grime J, Blenkinsopp A, Raynor DK, Pollock K, Knapp P. The role and value of written information for patients about individual medicines: a systematic review. Heal Expect. 2007;10(3):286–298. doi:10.1111/j.1369-7625.2007.00454.x
   PubMed Web of Science ®Google Scholar
• Gibson Smith K, Booth JL, Stewart D, Pfleger S, McIver L, Maclure K. Supporting shared decision-making and people’s understanding of medicines: an exploration of the acceptability and comprehensibility of patient information. Pharm Pract (Granada). 2017;15(4):1–7. doi:10.18549/PharmPract.2017.04.1082
   Web of Science ®Google Scholar
• Morrow DG, Weiner M, Young J, Steinley D, Deer M, Murray MD. Improving medication knowledge among older adults with heart failure: a patient-centered approach to instruction design. Gerontologist. 2005;45(4):545–552. doi:10.1093/geront/45.4.545
   PubMed Web of Science ®Google Scholar
• Mai A, Aslani P. Impact of Vietnamese written and verbal medicine information on Vietnamese-speaking Australians’ knowledge and satisfaction. Br J Clin Pharmacol. 2007;64(4):527–535. doi:10.1111/j.1365-2125.2007.02968.x
   Web of Science ®Google Scholar
• Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J. Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: effect on patients’ knowledge. PLoS One. 2019;14(1):1–15. doi:10.1371/journal.pone.0210395
   Web of Science ®Google Scholar
• Williams VS, Morlock RJ, Feltner D. Psychometric evaluation of a visual analog scale for the assessment of anxiety. Health Qual Life Outcomes. 2010;8:57. doi:10.1186/1477-7525-8-57
   PubMed Web of Science ®Google Scholar
• Ruel E, Edward Wagner W, Gillespie BJ. Pretesting and pilot testing. In: The Practice of Survey Research: Theory and Applications. SAGE Publications; 2016.
   Google Scholar
• Bloom BS. Learning for mastery. instruction and curriculum. regional education laboratory for the Carolinas and Virginia. Eval Comment. 1968;1:1–12.
   Google Scholar
• Hill J, Bird H. The development and evaluation of a drug information leaflet for patients with rheumatoid arthritis. Rheumatology. 2003;42(1):66–70. doi:10.1093/rheumatology/keg032
   Web of Science ®Google Scholar
• Mansoor L, Dowse R. Written medicines information for South African HIV/AIDS patients: does it enhance understanding of co-trimoxazole therapy? Health Educ Res. 2006;22(1):37–48. doi:10.1093/her/cyl039
   Web of Science ®Google Scholar
• Curtis LM, Mullen RJ, Russell A, et al. An efficacy trial of an electronic health record-based strategy to inform patients on safe medication use: the role of written and spoken communication. Patient Educ Couns. 2016;99(9):1489–1495. doi:10.1016/j.pec.2016.07.004
   Web of Science ®Google Scholar
• Puspitasari HP, Aslani P, Krass I. Pharmacists’ and consumers’ viewpoints on counselling on prescription medicines in Australian community pharmacies. Int J Pharm Pract. 2010;18(4):202–208. doi:10.1111/j.2042-7174.2010.00041.x
   Google Scholar
• Phueanpinit P, Jarernsiripornkul N, Pongwecharak J, Krska J. Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. Int J Clin Pharm. 2014;36(6):1205–1212. doi:10.1007/s11096-014-0018-7
   PubMed Web of Science ®Google Scholar
• Schmitt MR, Miller MJ, Harrison DL, et al. Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients’ risk awareness. Patient Educ Couns. 2010;83:391–397. doi:10.1016/j.pec.2010.10.032
   Web of Science ®Google Scholar
• Vander Stichele RH. Impact of Written Drug Information in Patient Package Inserts: Acceptance and Impact on Benefit/Risk Perception [Thesis for the Degree of Doctor in Medical Sciences]. Gent, Belgium: Ghent University; 2004.
   Google Scholar
• Tong V, Raynor DK, Blalock SJ, Aslani P. Exploring consumer opinions on the presentation of side effects information in-Australian Consumer Medicine Information leaflets. Health Expect. 2016;19(3):543–556. doi:10.1111/hex.12215
   Web of Science ®Google Scholar
• Knapp P, Raynor DK, Berry DC. Comparison of two methods of presenting risk information to patients about the side effects of medicines. Qual Saf Heal Care. 2004;13(3):176–180. doi:10.1136/qshc.2003.009076
   PubMed Web of Science ®Google Scholar
• Savaş S, Evcik D. Do undereducated patients read and understand written education materials? A pilot study in Isparta, Turkey. Scand J Rheumatol. 2001;30(2):99–102. doi:10.1080/03009740151095385
   Web of Science ®Google Scholar
• Akour A, Bardaweel S, Awwad O, Al-Muhaissen S, Hussein R. Impact of a pharmacist-provided information booklet on knowledge and attitudes towards oral contraception among Jordanian women: an interventional study. Eur J Contracept Reprod Health Care. 2017;22:459–464. doi:10.1080/13625187.2017.1412425
   PubMed Web of Science ®Google Scholar
• Adepu R, Swamy M. Development and evaluation of patient information leaflets (PIL) usefulness. Indian J Pharm Sci. 2012;74:174. doi:10.4103/0250-474X.103857
   Web of Science ®Google Scholar
• Ndwiga JM, Kikuvi G, Omolo JO. Factors influencing knowledge on completion of treatment among tb patients under directly observed treatment strategy, in selected health facilities in embu county, Kenya. Pan Afr Med J. 2016;25:234. doi:10.11604/pamj.2016.25.234.8761
   PubMedGoogle Scholar
• Hanprasertpong T, Rattanaprueksachart R, Janwadee S, et al. Comparison of the effectiveness of different counseling methods before second trimester genetic amniocentesis in Thailand. Prenat Diagn. 2013;33(12):1189–1193. doi:10.1002/pd.4222
   Web of Science ®Google Scholar
• Pérez-Jover V, Mira JJ, Carratala-Munuera C, et al. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. Int J Environ Res Public Health. 2018;15(2):310. doi:10.3390/ijerph15020310
   Web of Science ®Google Scholar
• Koo M, Krass I, Aslani P. Consumer opinions on medicines information and factors affecting its use - an Australian experience. Int J Pharm Pract. 2002;10(2):107–114. doi:10.1111/j.2042-7174.2002.tb00595.x
   Google Scholar
• Nicolson D, Knapp P, Raynor DK, Spoor P. Written information about individual medicines for consumers. Cochrane Database Syst Rev. 2009;15(2):CD002104. doi:10.1002/14651858.CD002104.pub3
   Web of Science ®Google Scholar
• Al-Ramahi R, Zaid AN, Kettana N, Sweileh W, Al-Jabi D. Attitudes of consumers and healthcare professionals towards the patient package inserts-a study in Palestine. Pharm Pract. 2012;10(1):57–63. doi:10.4321/S1886-36552012000100010
   Google Scholar
• Oldman M, Moore D, Collins S. Drug patient information leaflets in anaesthesia: effect on anxiety and patient satisfaction. Br J Anaesth. 2004;92(6):854–858. doi:10.1093/bja/aeh162
   Web of Science ®Google Scholar
• Vinker S, Eliyahu V, Yaphe J. The effect of drug information leaflets on patient behavior. Med Assoc J. 2007;9(5):383–386.
   Google Scholar
• Garrud P, Wood M, Stainsby L. Impact of risk information in a patient education leaflet. Patient Educ Couns. 2001;43(3):301–304. doi:10.1016/s0738-3991(00)00168-3
   Web of Science ®Google Scholar
• Ghimirey A, Sapkota B, Shrestha S, Basnet N, Shankar PR, Sapkota S. Evaluation of pharmacist counseling in improving knowledge, attitude, and practice in chronic kidney disease patients. SAGE Open Med. 2013;1:2050312113516111. doi:10.1177/2050312113516111
   Google Scholar
• Klimek L, Bergmann KC, Biedermann T, et al. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in case of allergic rhinitis in everyday health care. Allergo J Int. 2017;26(1):16–24. doi:10.1007/s40629-016-0006-7
   PubMedGoogle Scholar